ID: ALA147376

Max Phase: Preclinical

Molecular Formula: C21H20O5

Molecular Weight: 352.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(C)COc1ccc2c(=O)c3cccc(CC(=O)OC)c3oc2c1C

Standard InChI:  InChI=1S/C21H20O5/c1-12(2)11-25-17-9-8-16-19(23)15-7-5-6-14(10-18(22)24-4)21(15)26-20(16)13(17)3/h5-9H,1,10-11H2,2-4H3

Standard InChI Key:  PJDYIGQWQQFMLI-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.39Molecular Weight (Monoisotopic): 352.1311AlogP: 3.93#Rotatable Bonds: 5
Polar Surface Area: 65.74Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.40Np Likeness Score: -0.02

References

1. Gobbi S, Rampa A, Bisi A, Belluti F, Valenti P, Caputo A, Zampiron A, Carrara M..  (2002)  Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.,  45  (22): [PMID:12383019] [10.1021/jm020929p]

Source